Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Ends Nearly 2-Year Drought In Biosimilar Action Package Postings

Nov 08 2018

• By Sue Sutter

dramatic sunset over cracked earth. Desert landscape background. Global warming concept

Related Content

Biosimilar Action Packages Low On US FDA Priority List For Redaction And Posting

Sep 24 2018

Keeping Track: FDA Starts November With A Bang

Nov 02 2018

Mylan’s Fulphila: First Neulasta Biosimilar’s Road To US Market Slowed Only By Product Quality, GMP Deficiencies

Nov 08 2018

Related Companies

Boehringer Ingelheim GmbH

Amgen, Inc.

Viatris Inc.

Samsung Bioepis Co., Ltd.

Johnson & Johnson

Novartis AG

Celltrion, Inc.

Pfizer Inc.

Additional Topics

United States Biosimilars Biologics Regulation Drug Review Profile BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window